These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26604858)

  • 21. Contribution of the BRAF mutation analysis in calcified thyroid nodules.
    Yoo EY; Shin JH; Ko EY; Han BK
    AJR Am J Roentgenol; 2012 Apr; 198(4):891-5. PubMed ID: 22451557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mutational analysis in the diagnostic work-up of thyroid nodules: the real impact in a center with large experience in thyroid cytopathology.
    Macerola E; Rago T; Proietti A; Basolo F; Vitti P
    J Endocrinol Invest; 2019 Feb; 42(2):157-166. PubMed ID: 29704233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a Molecular Assay for Detection and Quantification of the BRAF Variation in Residual Tissue From Thyroid Nodule Fine-Needle Aspiration Biopsy Specimens.
    Fu G; Chazen RS; MacMillan C; Witterick IJ
    JAMA Netw Open; 2021 Oct; 4(10):e2127243. PubMed ID: 34613404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
    Chung KW; Yang SK; Lee GK; Kim EY; Kwon S; Lee SH; Park DJ; Lee HS; Cho BY; Lee ES; Kim SW
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of different methodologies on the detection of point mutations in routine air-dried fine needle aspiration (FNA) smears.
    Rehfeld C; Münz S; Krogdahl A; Jensen EM; Siebolts U; Ferraz C; Bösenberg E; Hegedüs L; Paschke R; Eszlinger M
    Horm Metab Res; 2013 Jul; 45(7):513-7. PubMed ID: 23508716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial clinical experience with BRAF(V600E) mutation analysis of core-needle biopsy specimens from thyroid nodules.
    Choi SH; Baek JH; Lee JH; Choi YJ; Ha EJ; Song DE; Kim JK; Chung KW; Kim TY; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):607-13. PubMed ID: 26215382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity.
    Krane JF; Cibas ES; Alexander EK; Paschke R; Eszlinger M
    Cancer Cytopathol; 2015 Jun; 123(6):356-61. PubMed ID: 25926393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules: A Prospective Study of
    Cho YY; Park SY; Shin JH; Oh YL; Choe JH; Kim JH; Kim JS; Yim HS; Kim YL; Ki CS; Kim TH; Chung JH; Kim SW
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings.
    Sapio MR; Posca D; Raggioli A; Guerra A; Marotta V; Deandrea M; Motta M; Limone PP; Troncone G; Caleo A; Rossi G; Fenzi G; Vitale M
    Clin Endocrinol (Oxf); 2007 May; 66(5):678-83. PubMed ID: 17381488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRAF(V600E) assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay.
    Guerra A; Di Stasi V; Zeppa P; Faggiano A; Marotta V; Vitale M
    Endocrine; 2014 Mar; 45(2):249-55. PubMed ID: 23775008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation.
    Kwon HJ; Kim EK; Kwak JY
    Pathol Res Pract; 2015 Sep; 211(9):671-6. PubMed ID: 26187369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of
    Chen X; Zhou Q; Wang F; Zhang F; Du H; Zhang Q; Wu W; Gong X
    AJNR Am J Neuroradiol; 2018 Dec; 39(12):2360-2365. PubMed ID: 30498021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the Anyplex BRAF V600E real-time detection assay using dual-priming oligonucleotide technology in fine-needle aspirates of thyroid nodules.
    Choi R; Park KS; Kim JW; Ki CS
    Ann Lab Med; 2015 Nov; 35(6):624-9. PubMed ID: 26354351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PREDICTIVE VALUE OF SOMATIC MUTATIONS FOR THE DEVELOPMENT OF MALIGNANCY IN THYROID NODULES BY CYTOPATHOLOGY.
    Halászlaki C; Tóbiás B; Balla B; Kósa JP; Horányi J; Bölöny E; Nagy Z; Speer G; Járay B; Székely E; Istók R; Székely T; Putz Z; Dank M; Lakatos P; Takács I
    Endocr Pract; 2016 Sep; 22(9):1081-7. PubMed ID: 27214302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRAFV600E mutation testing in fine needle aspirates of thyroid nodules: potential value of real-time PCR.
    Kwak JY; Han KH; Yoon JH; Kim EK; Moon HJ; Kim YL; Park SJ; Choi JR
    Ann Clin Lab Sci; 2012; 42(3):258-65. PubMed ID: 22964613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testing for BRAF (V600E) Mutation in Thyroid Nodules with Fine-Needle Aspiration (FNA) Read as Suspicious for Malignancy (Bethesda V, Thy4, TIR4): a Systematic Review and Meta-analysis.
    Trimboli P; Scappaticcio L; Treglia G; Guidobaldi L; Bongiovanni M; Giovanella L
    Endocr Pathol; 2020 Mar; 31(1):57-66. PubMed ID: 31811566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status.
    Kim SK; Hwang TS; Yoo YB; Han HS; Kim DL; Song KH; Lim SD; Kim WS; Paik NS
    J Clin Endocrinol Metab; 2011 Mar; 96(3):658-64. PubMed ID: 21239517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility and performance of the Idylla™ NRAS/BRAF cartridge mutation assay on thyroid liquid-based fine-needle aspiration.
    Hamadou M; Lopez J; Benzerdjeb N; Cugnet-Anceau C; Schnoering G; Besançon J; Mezrag S; Lapras V; Denier ML; Descotes F; Decaussin-Petrucci M
    Diagn Cytopathol; 2021 Dec; 49(12):1265-1271. PubMed ID: 34698448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.
    Kim SK; Kim DL; Han HS; Kim WS; Kim SJ; Moon WJ; Oh SY; Hwang TS
    Diagn Mol Pathol; 2008 Jun; 17(2):118-25. PubMed ID: 18382358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.